Pharmacy Practice

Supreme Court Overturns Roe v. Wade

Published: June 24, 2022

Today the Supreme Court voted to overturn Roe v. Wade, which created a federal right to abortion in 1973.  The ruling in the case, Dobbs v. Jackson Women’s Health Organization, ends the federal right and gives states discretion to determine the limits of access to abortion-related services. 

The decision will result in a national patchwork of reproductive health access, with some states prohibiting or limiting access, and others maintaining relatively free access to services. 

ASHP is evaluating Dobbs’ potential impact on clinicians, including pharmacists. Some states are considering laws that would impose criminal and/or civil penalties on clinicians who provide abortion-related services, potentially including dispensing of medications for termination of pregnancy, IVF, and management of ectopic pregnancies. Other states have existing laws restricting access to reproductive health services that will go into effect based on the Dobbs decision. Provision of telehealth services by out-of-state clinicians may also be impacted. 

ASHP will update members as additional information becomes available.

Posted June 24, 2022

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information